LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX) a diversified, global medical
device company, today announced that President and Chief Executive
Officer Brad Mason will present at the following conferences in June:
At 3:30 p.m. ET on Thursday, June 8, 2017 at the Jefferies 2017
Healthcare Conference in New York City.
At 1:00 p.m. ET on Wednesday, June 21, 2017 at the 2017 JMP Securities
Life Science Conference in New York City.
Live audio webcasts will be available on the Company's website at www.orthofix.com
by clicking on the Investors tab and then clicking the link on the
Events and Presentations page.
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, Texas, the Company
has four strategic business units: BioStim, Biologics, Extremity
Fixation and Spine Fixation. Orthofix products are widely distributed
via the Company's sales representatives and distributors. In addition,
Orthofix is collaborating on research and development activities with
leading clinical organizations such as Brown University, Sinai Hospital
of Baltimore, Cleveland Clinic, Texas Scottish Rite Hospital for
Children, and the Musculoskeletal Transplant Foundation. For more
information, please visit www.orthofix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170531006485/en/
Orthofix International N.V.
Denise Landry, 214-937-2529
Source: Orthofix International N.V.
News Provided by Acquire Media